Board approves plan to raise up to Rs 600 Crores
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Orchid Pharma's Board approved an enabling resolution to raise up to Rs 600 Crores. Funds may be raised via equity shares, convertible debentures, qualified institutions placement, private placement, public issue, or preferential issue, or any combination. No specific mode, instrument, or final amount decided yet. Shareholder and regulatory approvals may be required.
Potential equity dilution if funds are raised via equity route. No immediate impact as this is only an enabling resolution, not a confirmed issuance.